|
Market Closed -
Australian S.E.
09:10:15 19/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.009000 AUD | -10.00% |
|
-10.00% | -40.00% |
| 08-17 | Acrux Limited - Special Call | |
| 05-28 | Acrux licenses Lenzetto for Australian market for A$5.4 million | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 4.18M | - | - | - | - | - |
| 46.96B | |||||
| 39.63B | |||||
| 12.07B | |||||
| 11.61B | |||||
| 9.11B |
- Stock Market
- Stocks
- ACR Stock
- Charts Acrux Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
